From the Journals

RA-ILD: Tracking Function and CT

Conventional monitoring markers do not change before deaths in this predominantly mild cohort.

Share

A prospective cohort study of patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD) revealed that pulmonary function and imaging measures remained stable over two years, despite an 8% mortality rate. Conducted across three Brazilian centers, the study included 105 patients, focusing on pulmonary fibrosis and associated biomarkers. Although 80% of participants had pulmonary fibrosis, most exhibited mild disease, with no significant decline in forced vital capacity. The findings challenge traditional expectations of functional decline preceding mortality in ILD cases.

Original Source(s)

RA-ILD: Tracking Function and CT

  • by Kathryn Wighton

  • March 6, 2026

Related Content

Dry Eye Across Autoimmune Diseases

The nationwide analysis found the highest rates of dry eye disease among patients with Sjögren’s syndrome.

​​​​​​​PsA Treatment Options Expand

Phase 3 POETYK trial results support FDA approval of deucravacitinib for adults with active PsA.

Anti-CD146 Linked to Silica in Systemic Sclerosis

Comparative analysis across exposed workers, cancer controls, and healthy donors supports specificity.